Search clinical trials for: Recombinant human endostatin

Total 25263 results

Nanjing First Hospital, Nanjing Medical University

Recruiting

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Gastrointestinal Neoplasms

China
The First Affiliated Hospital of Xinxiang Medical...

Not yet recruiting

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

Locally Advanced Squamous Non-small Cell Lung Cancer
Chongqing University Cancer Hospital

Not yet recruiting

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Nasopharyngeal Carcinoma
Second Affiliated Hospital of Soochow University

Recruiting

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Advanced Solid Tumor | Refractory Tumor

China
Fudan University

Not yet recruiting

Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma

Advanced Mucosal Melanoma
Peking University Third Hospital

Not yet recruiting

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Cervical Cancer
Qianfoshan Hospital

Recruiting

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial (FTANLCNDG)

Non-Small-Cell Lung Cancer

China
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Colorectal Neoplasms
Anhui Chest Hospital

Not yet recruiting

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Affiliated Cancer Hospital & Institute of Guangzhou...

Not yet recruiting

Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC

Non Small Cell Lung Cancer | Endostatin

China
Hebei Medical University

Recruiting

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

Leptomeningeal Metastasis | Immune Checkpoint Inhibitor | Endostatin

China
Beijing Sanbo Brain Hospital

Recruiting

Modified CV Regimen in Optic Pathway Glioma

Optic Glioma | Pediatric Brain Tumor, Optic Nerve Glioma

China
Qilu Hospital of Shandong University

Recruiting

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Squamous Non-small Cell Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Advanced or Metastatic NSCLC

China
Yong Chen

Recruiting

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Other Disorders of Soft Tissues

China
Shanghai Chest Hospital
Wuhan University

Not yet recruiting

Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC (RELIEF)

Lung Cancer
Hui Bu

Not yet recruiting

Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Leptomeningeal Metastasis
Beijing Sanbo Brain Hospital

Recruiting

Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas

Glioblastoma, Recurrent | Lower Grade Glioma, Recurrent

China
Jiangsu Cancer Institute & Hospital

Not yet recruiting

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Beijing Sanbo Brain Hospital

Completed

Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas

Low-grade Glioma | Pediatric Brain Tumor

China
Yuhong Li

Completed

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital with Nanjing Medical...

Terminated

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

Esophageal

China
Second Xiangya Hospital of Central South University

Enrolling by invitation

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

Non-small Cell Lung Cancer

China
Sun Yan
Peking University; Peking University Cancer Hospital & Institute

Unknown

Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors (SLICER)

Head and Neck Neoplasms

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors

NSCLC | Solid Tumor

China
Acrotech Biopharma Inc.
National Cancer Institute (NCI)

Completed

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Sarcoma | Lymphoma | Leukemia | Neuroblastoma | Brain Tumors | Wilms Tumor

United States
Tianjin Medical University Cancer Institute and...

Completed

Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma

Soft Tissue Sarcoma, Adult, Stage IIB

China
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Zhejiang Cancer Hospital

Unknown

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Cervical Cancer

China
Xijing Hospital

Unknown

Breast Cancer Treatment Based on Organ-like Culture

Breast Cancer Organoids

China
Zhejiang Cancer Hospital

Unknown

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Breast Cancer

China
Sichuan Provincial People's Hospital
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer. (EXECC)

Quality of Life

China
China International Medical Foundation
Chinese Society of Clinical Oncology

Unknown

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

Nasopharyngeal Neoplasms

China
Afﬁliated Hospital of North Sichuan Medical College
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Quality of Life

China
Yun-fei Xia

Unknown

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Nasopharyngeal Carcinoma

China
Xinjiang Medical University

Unknown

Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer

Breast Neoplasms

China
Zhejiang Cancer Hospital
Fudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaborators

Completed

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Stage III Non-small-Cell Lung Cancer

China
Chinese PLA General Hospital

Unknown

Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)

Hepatocellular Carcinoma

China
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaborators

Unknown

Endostar First-line Treatment of Advanced NSCLC

Non Small Cell Lung Cancer
Peking University Cancer Hospital & Institute

Unknown

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Melanoma

China
Yong Zhang,MD

Unknown

Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma (ECWHCCFLACC)

Cervical Carcinoma

China
Beijing Tiantan Hospital
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Endostatin)

Neurofibromatosis Type 2 | Vestibular Schwannoma

China
Zaiwen Fan

Unknown

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Advanced Cancer | Lung Cancer, Nonsmall Cell
Xinqiao Hospital of Chongqing

Unknown

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Non Small Cell Lung Cancer | Malignant Hydrothorax
First Affiliated Hospital of Guangxi Medical University

Unknown

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Anhui Provincial Hospital

Unknown

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Adenocarcinoma of Lung

China
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

Neuroblastoma

China
Guangzhou Double Bioproducts Co., Ltd

Unknown

E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Head and Neck Neoplasms

China
Tianjin Medical University Cancer Institute and...

Completed

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Non Small Cell Lung Cancer

China
Zhejiang University
Beta Pharma, Inc.; Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Lung Cancer

China

3

Subscribe